Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 179, Issue 4, Pages 2131-2141Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2011.06.028
Keywords
-
Categories
Funding
- NIH [CA138759, HL087001]
Ask authors/readers for more resources
Signal transducer and activator of transcription 3 (Stat3) is a potent transcription factor with diverse biological functions. Overexpression of constitutively active form Stat3C in lung alveolar type II (AT II) epithelial cells in CCSP-rtTA/(tetO)(7)-CMV-Stat3C bitransgenic mice induces chronic inflammation and lung bronchioalveolar adenocarcinoma. In the present study, the population of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) was significantly increased in lung and blood of doxycycline-treated bitransgenic mice, but CD4(+) and CD8(+) T cells were decreased. In bronchioalveolar lavage fluid and plasma of doxycycline-treated bitransgenic mice, concentrations of MDSC-stimulating cytokines IL-1 beta, IL-6, IL-10, IL-13, INF-gamma, TNF-alpha, and GM-CSF were significantly increased, which stimulated alveolar monocytes/macrophages to CD11b(+) Gr-1(+) cell conversion in vitro. Phosphorylation of proto-oncogenic intracellular signaling molecules Stat3, Erk1/2, and P38 was significantly increased in CD11b(+)Gr-1(+) cells from lung and blood of doxycycline-treated bitransgenic mice. CD11b(+)Gr-1(+) cells from lung of doxycycline-treated bitransgenic mice strongly inhibited proliferation and function of wild-type CD4(+) T cells in vitro. These findings support the concept that persistent activation of Stat3 induces inflammation during lung cancer by promoting MDSC-mediated immune suppression. (Am J Pathol 2011, 179:2131-2141; DOI: 10.1016/j.ajpath.2011.06.028)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available